A Randomized Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability and Antiviral Activity of 12 Weeks??? Treatment with a New Antiviral Human CMV Drug
|Effective start/end date||5/5/10 → 12/20/12|
- AiCuris GmbH & Co. KG
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.